Sapigen Biologix Profile
Key Indicators
- Authorised Capital ₹ 630.00 Cr
- Paid Up Capital ₹ 624.00 Cr
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 322.77 Cr
- Revenue Growth %
- Ebitda
- Net Worth 81.12%
- Total Assets 202.12%
About Sapigen Biologix
Sapigen Biologix Private Limited (SBPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 17 October 2020 (Four years and three months 24 days old ). Its registered office is in Khorda, Odisha, India.
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 630.00 Cr and a paid-up capital of Rs 624.00 Cr.
The company currently has active open charges totaling ₹322.77 Cr.
The Key Managerial Personnel (KMP) at Sapigen Biologix Private Limited India are Cherukupalli Kumar as COMPANY SECRETARY and Gopinathan Kumar as Cfo. Krishna Ella, Melappati Chakravarthy, Jalachari Ella, and One other member serve as directors at the Company.
Company Details
-
Location
Khorda, Odisha, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U73100OD2020PTC046324
-
Company No.
144962
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Oct 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Cuttack
Industry
Who are the key members and board of directors at Sapigen Biologix?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raches Ella
|
Managing Director | 17-Oct-2020 | Current |
| Cherukupalli Kumar | Company Secretary | 06-Jun-2024 | Current |
| Gopinathan Kumar | CFO | 03-Oct-2024 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Krishna Ella
|
Director | 17-Oct-2020 | Current |
|
Melappati Chakravarthy
|
Director | 20-Feb-2023 | Current |
|
Jalachari Ella
|
Director | 18-Mar-2021 | Current |
Financial Performance of Sapigen Biologix.
Sapigen Biologix Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 81.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sapigen Biologix?
In 2023, Sapigen Biologix had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Wadi Surgicals Private LimitedRaches Ella is a mutual person
-
Innova Agri Bio Park Private LimitedJalachari Ella is a mutual person
-
Ella FoundationKrishna Ella is a mutual person
-
Chiron Behring Vaccines Private LimitedRaches Ella is a mutual person
-
Bharat Biotech International LimitedKrishna Ella and Melappati Chakravarthy are mutual person
-
Biovet Private LimitedJalachari Ella and Raches Ella are mutual person
Charges (Loans)
₹322.77 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 200.00 Cr
- Others : 122.77 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Mar 2022 | Others | ₹122.77 Cr | Open |
| 27 Dec 2021 | State Bank Of India | ₹200.00 Cr | Open |
How Many Employees Work at Sapigen Biologix?
Sapigen Biologix has a workforce of 107 employees as of Nov 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sapigen Biologix, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sapigen Biologix's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
